目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. INDIA API MARKET, BY BUSINESS MODE
6.1. Overview
6.2. Captive API
6.3. Merchant API

7. INDIA API MARKET, BY SYNTHESIS TYPE
7.1. Overview
7.2. Synthetic
7.3. Biotech

8. INDIA API MARKET, BY DRUG TYPE
8.1. Overview
8.2. Generic
8.3. Branded

9. INDIA API MARKET, BY APPLICATION
9.1. Overview
9.2. Cardiology
9.3. Oncology
9.4. Pulmonology
9.5. Neurology
9.6. Orthopedic
9.7. Ophthalmology
9.8. Other Applications

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the India API Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the India API Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Aurobindo Pharma
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Novartis AG
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Lupin Ltd
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. BASF SE
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Viatris Inc.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. SANOFI INC.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. GlaxoSmithKline PLC
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Pfizer Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Dr. Reddy's Laboratories Ltd
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Sun Pharmaceutical Industries Ltd
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 INDIA API MARKET, SYNOPSIS, 2019-2032
TABLE 2 INDIA API MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 INDIA API MARKET, BY BUSINESS MODE, 2019-2032 (USD BILLION)
TABLE 4 INDIA API MARKET, BY SYNTHESIS TYPE, 2019-2032 (USD BILLION)
TABLE 5 INDIA API MARKET, BY DRUG TYPE, 2019-2032 (USD BILLION)
TABLE 6 INDIA API MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE INDIA API MARKET
FIGURE 3 MARKET DYNAMICS FOR THE INDIA API MARKET
FIGURE 4 INDIA API MARKET, SHARE (%), BY BUSINESS MODE, 2023
FIGURE 5 INDIA API MARKET, SHARE (%), BY SYNTHESIS TYPE, 2023
FIGURE 6 INDIA API MARKET, SHARE (%), BY DRUG TYPE, 2023
FIGURE 7 INDIA API MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 8 INDIA API MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 9 AUROBINDO PHARMA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 10 AUROBINDO PHARMA: SWOT ANALYSIS
FIGURE 11 BOEHRINGER INGELHEIM GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS
FIGURE 13 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 NOVARTIS AG: SWOT ANALYSIS
FIGURE 15 LUPIN LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 LUPIN LTD: SWOT ANALYSIS
FIGURE 17 BASF SE.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 BASF SE.: SWOT ANALYSIS
FIGURE 19 VIATRIS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 VIATRIS INC.: SWOT ANALYSIS
FIGURE 21 SANOFI INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 SANOFI INC.: SWOT ANALYSIS
FIGURE 23 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 PFIZER INC.: SWOT ANALYSIS
FIGURE 27 DR. REDDY'S LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 DR. REDDY'S LABORATORIES LTD: SWOT ANALYSIS
FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 SUN PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS